ADHD in the News 2024-05-30

ADHD and Adults: Main Line Area Experts on the Rise in Diagnoses

Parents and other grownups are currently being diagnosed with the disorder at the same rate as children. Why now?

FDA Approves Nonstimulant Liquid Onyda XR for ADHD

The US Food and Drug Administration (FDA) has approved Onyda XR (clonidine hydrochloride) for the treatment of attention-deficit/hyperactivity disorder (ADHD), drug manufacturer Tris Pharma announced in a statement. The drug is the first approved liquid nonstimulant ADHD medication. The once-daily extended-release oral suspension, with nighttime dosing, can be used alone or as an adjunctive therapy to FDA-approved stimulant medications in pediatric patients aged 6 years or older.

ADHD game developer Akili Interactive to be taken private, after $34M sale

After announcing it would start selling its assets earlier this year, along with laying off nearly half the company, the medical app developer Akili Interactive has found a willing buyer.

New drug-free treatment could change protocol for people dealing with ADHD

A new treatment for ADHD and other cognitive issues uses a neuro feedback headband to increase blood flow and oxygen to the prefrontal cortex. Fifth grader Clinton Pierce details how Mendi has helped him.

Methylphenidate Improves Emotional Lability Among Children With ADHD

Delayed-release/extended-release methylphenidate improves emotional lability among children with attention-deficit/hyperactivity disorder (ADHD), according to new research published in the Journal of Attention Disorders.

Prenatal Fluoride Exposure Linked to Neurobehavioral Problems

In utero fluoride exposure at normal U.S. municipal ranges was associated with increased neurobehavioral problems in young kids, a prospective cohort study of 229 mother-child pairs in Los Angeles suggested.

Study promotes digital help for adults with ADHD

Digital health experts at Flinders University are developing a mobile self-monitoring app model to assist adults with Attention-Deficit Hyperactivity Disorder (ADHD) take a more pro-active role in their "wellness journey."

In Utero Exposure to Antiseizure Medications Tied to Neurodevelopmental Effects

The use of some prenatal antiseizure medications (ASMs) during pregnancy may result in adverse postnatal neurodevelopmental outcomes, according to study findings published in Neurology.

Research shows ADHD goes beyond core symptoms and needs a holistic approach

New research has revealed the extensive impact of Attention Deficit Hyperactivity Disorder (ADHD) highlighting mental health vulnerabilities, physical health risks, and societal implications, emphasizing the need for a holistic approach to properly manage this condition.

Helping Patients Navigate the Stimulant Shortage and Other Challenges in Adult ADHD

Unprecedented demand, supply shortages, and production delays have resulted in an ongoing shortage of stimulant medications to treat adult attention-deficit/hyperactivity disorder (ADHD), placing both patients and providers in a frustrating situation.

No, sugar doesn’t make your kids hyperactive

It’s a Saturday afternoon at a kids’ birthday party. Hordes of children are swarming between the spread of birthday treats and party games. Half-eaten cupcakes, biscuits and lollies litter the floor, and the kids seem to have gained superhuman speed and bounce-off-the-wall energy. But is sugar to blame?

Neurodivergent Kids Flourish When They’re Taught How Their Brains Work (Opinion)

When teachers and parents talk to kids about having ADHD, autism or learning disabilities, they set them up for success